ArticleThe Journal of international medical research2026
Application of hand-drawn bronchial navigation and rapid on-site evaluation combined with endobronchial ultrasound for the diagnosis of peripheral lung lesions.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo investigate the clinical value of radial endobronchial ultrasound (rEBUS) combined with rapid on-site evaluation (ROSE) under hand-drawn bronchial navigation (HBN) planning for the diagnosis of peripheral pulmonary lesions.MethodsA total of 186 patients were enrolled in this retrospective case-control study and classified into three groups according to the intervention method: rEBUS group (n = 74), HBN-rEBUS group (n = 57), and HBN-rEBUS-ROSE group (n = 54). The final diagnostic yield, lesion detection rate, time to lesion localization, number of biopsies performed, and incidence of complications were compared across the three groups.ResultsThe lesion detection rate was higher in the HBN-rEBUS group than in the rEBUS group, and the HBN-rEBUS group demonstrated fewer ultrasound probe passes and a shorter time to lesion localization (p < 0.001). The HBN-rEBUS-ROSE group required fewer biopsies and had a lower incidence of bleeding than the HBN-rEBUS group (p < 0.001). The HBN-rEBUS-ROSE group also achieved a higher diagnostic yield than both the rEBUS and HBN-rEBUS groups (p < 0.05).ConclusionHBN-rEBUS facilitates faster and more precise localization of peripheral pulmonary lesions, shortens procedural duration, and, when combined with ROSE, reduces bleeding and improves the diagnostic yield of peripheral pulmonary lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.